NEUTRA CORP. (NTRR)

↓ Download CSV

CIK 0001512886 · OTC · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Incorporated WY
  • Fiscal year ends Jan 31

In fiscal 2023, NEUTRA CORP. reported revenue of $68.0K, down 26.1% from the prior year. The company ran a net loss, with a net margin of -825.7% and a gross margin of 51.9%. It held $75.2K in total assets against $813.8K in total liabilities.

Key ratios (FY2023)

51.9%
Gross margin
-437.8%
Operating margin
-825.7%
Net margin
-26.1%
Revenue growth (YoY)
Metric (FY)2023202220212020201920182017201620152014
Revenue$68.0K$92.0K$9.7K$6.4K
Cost of Revenue$32.7K$60.9K$42.9K
Gross Profit$35.3K$31.2K-$33.3K$6.4K
Operating Income-$297.7K-$583.6K-$478.7K-$394.2K-$1.71M-$163.7K-$370.7K-$1.04M-$635.9K-$965.9K
Net Income-$561.4K-$632.9K-$538.9K-$695.6K-$2.43M-$519.0K-$867.9K-$1.44M-$1.90M-$1.26M
Total Assets$75.2K$130.9K$190.8K$182.3K$163.6K$12.3K$0$284$6.6K$46.6K
Total Liabilities$813.8K$1.15M$1.00M$1.03M$1.27M$776.8K$675.6K$425.6K$392.5K$551.3K
Shareholders' Equity-$773.8K-$1.27M-$967.5K-$849.5K-$1.11M-$764.5K-$675.6K-$425.3K-$386.0K-$504.8K
Cash & Equivalents$2.0K$1.1K$23.3K$177.2K$0$0$0$284$6.6K$46.6K
Operating Cash Flow-$153.2K-$405.6K-$412.4K-$181.6K-$417.0K-$108.9K-$211.6K-$546.5K-$800.1K
Capital Expenditures$40.2K$196.5K
Shares Outstanding2.74B1.78B1.49B616.20M34.13M6.84M2.98M1.72M903.2K14.90M